Clinical Trial Update: Real-world Study to Describe the Effectiveness and Safety Outcomes of Jardiance in Chinese Patients With Heart Failure and Preserved Ejection Fraction

View source ↗

Summary

This clinical trial update outlines a real-world study to evaluate the effectiveness and safety of Jardiance (empagliflozin) in Chinese patients with heart fail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Drugs mentioned

• Jardiance (empagliflozin)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Heart Failure, Preserved Ejection Fraction | Status: NOT_YET_RECRUITING